ITRACONAZOLE

ITRACONAZOLE was reported 11837 times

ITRACONAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FORCED EXPIRATORY VOLUME 16 0.4571
1 APPARENT MINERALOCORTICOID EXCESS 17 0.2931
2 GRANULOMATOUS ROSACEA 14 0.2857
3 CUTANEOUS SPOROTRICHOSIS 11 0.2292
4 PSEUDOALDOSTERONISM 33 0.1667
5 POLYGLANDULAR DISORDER 11 0.1618
6 PARATHYROID GLAND ENLARGEMENT 23 0.1608
7 PSEUDOHYPONATRAEMIA 19 0.1387
8 CHROMOBLASTOMYCOSIS 11 0.1294
9 FLUOROSIS 11 0.1279
10 PHAEHYPHOMYCOSIS 17 0.1269
11 SPOROTRICHOSIS 12 0.1212
12 UPPER RESPIRATORY FUNGAL INFECTION 23 0.1211
13 PULMONARY HISTOPLASMOSIS 12 0.1200
14 PHAEOHYPHOMYCOSIS 40 0.0835
15 FUNGAL ENDOCARDITIS 24 0.0797
16 LIP SQUAMOUS CELL CARCINOMA 13 0.0774
17 DISSEMINATED BLASTOMYCOSIS 13 0.0760
18 ALTERNARIA INFECTION 28 0.0753
19 MYCOTIC ENDOPHTHALMITIS 13 0.0688
20 HISTOPLASMOSIS 112 0.0632
21 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 57 0.0615
22 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 50 0.0608
23 KERATITIS FUNGAL 12 0.0577
24 ANAEMIA FOLATE DEFICIENCY 11 0.0570
25 ASPERGILLOMA 18 0.0563
26 PENICILLIUM INFECTION 10 0.0556
27 HISTOPLASMOSIS DISSEMINATED 88 0.0554
28 IDIOPATHIC PNEUMONIA SYNDROME 16 0.0537
29 ASPERGILLOSIS 69 0.0528
30 TRICHOSPORON INFECTION 20 0.0494
31 SYSTEMIC MYCOSIS 57 0.0488
32 LUNG TRANSPLANT REJECTION 30 0.0455
33 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 14 0.0418
34 CANDIDA PNEUMONIA 13 0.0402
35 SKIN CANDIDA 21 0.0402
36 ASPERGILLUS TEST POSITIVE 12 0.0390
37 LOWER RESPIRATORY TRACT INFECTION FUNGAL 15 0.0386
38 ENGRAFT FAILURE 11 0.0383
39 SCEDOSPORIUM INFECTION 27 0.0382
40 BLASTOMYCOSIS 18 0.0370
41 DERMATOPHYTOSIS 10 0.0352
42 CEREBRAL ASPERGILLOSIS 21 0.0341
43 EYE INFECTION FUNGAL 13 0.0336
44 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 12 0.0334
45 ADRENAL SUPPRESSION 28 0.0332
46 MORAXELLA INFECTION 9 0.0328
47 BLOOD ALKALINE PHOSPHATASE ABNORMAL 29 0.0322
48 ZYGOMYCOSIS 15 0.0321
49 DISSEMINATED ASPERGILLOSIS 15 0.0318
50 CYTOMEGALOVIRUS TEST POSITIVE 55 0.0308
51 ASPERGILLUS INFECTION 198 0.0301
52 ATOPY 8 0.0288
53 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 10 0.0285
54 BRONCHOPULMONARY ASPERGILLOSIS 215 0.0277
55 RESPIRATORY TRACT INFECTION FUNGAL 14 0.0265
56 CARDIAC VALVE VEGETATION 12 0.0247
57 CANDIDA TEST POSITIVE 10 0.0239
58 PULMONARY MYCOSIS 18 0.0231
59 FUSARIUM INFECTION 16 0.0229
60 DISSEMINATED MUCORMYCOSIS 9 0.0228
61 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 63 0.0228
62 PANCREATITIS HAEMORRHAGIC 10 0.0216
63 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 11 0.0210
64 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 15 0.0209
65 BRADYARRHYTHMIA 33 0.0201
66 ACUTE GRAFT VERSUS HOST DISEASE 91 0.0199
67 OBLITERATIVE BRONCHIOLITIS 26 0.0198
68 MYCOBACTERIAL INFECTION 33 0.0191
69 SINUSITIS FUNGAL 15 0.0187
70 CUSHING'S SYNDROME 12 0.0173
71 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 57 0.0172
72 CORNEAL EPITHELIUM DEFECT 10 0.0172
73 ACUTE MYELOID LEUKAEMIA RECURRENT 36 0.0168
74 LIPOHYPERTROPHY 10 0.0161
75 BRONCHIAL DISORDER 25 0.0161
76 CHRONIC HEPATITIS 13 0.0160
77 COMPLICATIONS OF TRANSPLANT SURGERY 8 0.0158
78 ILEUS PARALYTIC 70 0.0157
79 FUNGAL SEPSIS 13 0.0156
80 SEPTIC EMBOLUS 13 0.0156
81 PNEUMONIA FUNGAL 61 0.0154
82 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 21 0.0149
83 HYPOPARATHYROIDISM 11 0.0143
84 CORNEAL PERFORATION 9 0.0143
85 COCCIDIOIDOMYCOSIS 17 0.0142
86 BLOOD CORTISOL DECREASED 9 0.0141
87 PULMONARY CAVITATION 12 0.0138
88 LUNG OPACITY 36 0.0136
89 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 8 0.0135
90 ANTERIOR CHAMBER INFLAMMATION 8 0.0134
91 MITOCHONDRIAL TOXICITY 11 0.0134
92 PULMONARY NOCARDIOSIS 11 0.0133
93 ALANINE AMINOTRANSFERASE ABNORMAL 28 0.0133
94 BRONCHIECTASIS 88 0.0130
95 DRUG LEVEL CHANGED 8 0.0127
96 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 63 0.0126
97 PSEUDOMONAL SEPSIS 20 0.0114
98 ENDOCRINE DISORDER 14 0.0109
99 EPSTEIN-BARR VIRAEMIA 12 0.0108
100 PNEUMONIA CYTOMEGALOVIRAL 21 0.0108
101 BLOOD IMMUNOGLOBULIN E INCREASED 26 0.0107
102 HEART TRANSPLANT REJECTION 11 0.0106
103 PATHOGEN RESISTANCE 96 0.0105
104 VULVOVAGINAL CANDIDIASIS 14 0.0103
105 SPUTUM INCREASED 22 0.0102
106 NOCARDIOSIS 26 0.0102
107 ACINETOBACTER INFECTION 11 0.0100
108 PNEUMOCYSTIS JIROVECII INFECTION 12 0.0100
109 SKIN OEDEMA 10 0.0100
110 CUSHINGOID 32 0.0100
111 MYOPATHY 86 0.0099
112 ENTEROCOCCAL SEPSIS 8 0.0099
113 FORCED EXPIRATORY VOLUME DECREASED 28 0.0099
114 CARDIOVASCULAR INSUFFICIENCY 16 0.0098
115 VASOSPASM 9 0.0098
116 NEUTROPENIC SEPSIS 70 0.0098
117 STAPHYLOCOCCAL SEPSIS 48 0.0097
118 BLAST CELL COUNT INCREASED 10 0.0095
119 SECONDARY ADRENOCORTICAL INSUFFICIENCY 14 0.0093
120 CROSS SENSITIVITY REACTION 9 0.0092
121 CYTOMEGALOVIRUS VIRAEMIA 41 0.0092
122 STREPTOCOCCAL BACTERAEMIA 10 0.0092
123 ATYPICAL MYCOBACTERIAL INFECTION 13 0.0092
124 HAEMOPHILUS INFECTION 9 0.0092
125 CYSTITIS HAEMORRHAGIC 37 0.0092
126 ADRENAL INSUFFICIENCY 110 0.0091
127 CONTRAINDICATED PRODUCT PRESCRIBED 15 0.0089
128 CUTANEOUS VASCULITIS 32 0.0088
129 SYSTEMIC CANDIDA 22 0.0088
130 CORTISOL DECREASED 10 0.0087
131 PSEUDOMONAS INFECTION 75 0.0087
132 TRANSPLANT REJECTION 70 0.0087
133 PNEUMONIA KLEBSIELLA 16 0.0087
134 DRUG LEVEL BELOW THERAPEUTIC 48 0.0087
135 VARICELLA ZOSTER VIRUS INFECTION 18 0.0087
136 LYMPHANGIOSIS CARCINOMATOSA 9 0.0086
137 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 47 0.0086
138 GRAFT VERSUS HOST DISEASE IN SKIN 19 0.0086
139 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 20 0.0085
140 IMMUNE RECONSTITUTION SYNDROME 11 0.0085
141 DRUG LEVEL INCREASED 141 0.0085
142 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 15 0.0085
143 HYPOPROTEINAEMIA 16 0.0084
144 CARDIOTOXICITY 74 0.0083
145 CYTOMEGALOVIRUS INFECTION REACTIVATION 36 0.0081
146 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 9 0.0081
147 PNEUMOCYSTIS JIROVECI PNEUMONIA 18 0.0081
148 PSEUDOMEMBRANOUS COLITIS 18 0.0081
149 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 70 0.0079
150 PNEUMONIA PSEUDOMONAL 12 0.0078
151 MUCORMYCOSIS 20 0.0077
152 DRUG RESISTANCE 197 0.0077
153 GRAFT VERSUS HOST DISEASE 55 0.0076
154 LABELLED DRUG-DRUG INTERACTION ISSUE 11 0.0076
155 BLOOD AMYLASE INCREASED 13 0.0076
156 DRUG INTERACTION 1196 0.0075
157 CHRONIC GRAFT VERSUS HOST DISEASE 27 0.0075
158 PARADOXICAL DRUG REACTION 27 0.0073
159 CYTOMEGALOVIRUS INFECTION 120 0.0072
160 DISSEMINATED INTRAVASCULAR COAGULATION 98 0.0070
161 CEREBRAL VENTRICLE DILATATION 8 0.0069
162 FUNGAL SKIN INFECTION 28 0.0069
163 VENOOCCLUSIVE DISEASE 17 0.0068
164 BACTERIAL SEPSIS 22 0.0067
165 CRYPTOCOCCOSIS 11 0.0067
166 KLEBSIELLA INFECTION 34 0.0067
167 CYTOMEGALOVIRUS CHORIORETINITIS 13 0.0067
168 TORTICOLLIS 14 0.0066
169 MUCOUS MEMBRANE DISORDER 9 0.0066
170 ESCHERICHIA SEPSIS 19 0.0065
171 BK VIRUS INFECTION 22 0.0065
172 PULMONARY ALVEOLAR HAEMORRHAGE 36 0.0064
173 HISTIOCYTOSIS HAEMATOPHAGIC 19 0.0064
174 MYELITIS TRANSVERSE 9 0.0064
175 HYPERBILIRUBINAEMIA 66 0.0064
176 FUNGAEMIA 10 0.0063
177 MYCOBACTERIUM AVIUM COMPLEX INFECTION 17 0.0063
178 MENINGITIS CRYPTOCOCCAL 11 0.0063
179 CANDIDIASIS 25 0.0062
180 ACTINIC KERATOSIS 16 0.0062
181 ONYCHOMYCOSIS 27 0.0061
182 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 31 0.0061
183 PNEUMONIA PNEUMOCOCCAL 9 0.0061
184 STEROID DIABETES 9 0.0060
185 FUNGAL INFECTION 198 0.0059
186 HEPATOSPLENOMEGALY 15 0.0058
187 CHOLESTATIC LIVER INJURY 13 0.0058
188 LEFT VENTRICULAR FAILURE 20 0.0058
189 MULTIPLE-DRUG RESISTANCE 18 0.0058
190 LYMPHADENITIS 14 0.0058
191 ACUTE MYELOID LEUKAEMIA 90 0.0058
192 DISCHARGE 8 0.0058
193 APLASTIC ANAEMIA 30 0.0057
194 LUNG CONSOLIDATION 16 0.0057
195 TRANSPLANT FAILURE 14 0.0057
196 H1N1 INFLUENZA 8 0.0057
197 BLOOD CULTURE POSITIVE 17 0.0057
198 FEBRILE NEUTROPENIA 373 0.0056
199 TRANSPLANT DYSFUNCTION 10 0.0056
200 MYOSITIS 50 0.0056
201 ARTHROPOD STING 9 0.0054
202 NEUROTOXICITY 92 0.0052
203 CONJUNCTIVAL HAEMORRHAGE 20 0.0052
204 OSTEOPOROTIC FRACTURE 10 0.0052
205 STEM CELL TRANSPLANT 13 0.0052
206 GRANULOMA 18 0.0052
207 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 12 0.0052
208 GROWTH RETARDATION 15 0.0051
209 VENOOCCLUSIVE LIVER DISEASE 25 0.0051
210 PARAPARESIS 9 0.0050
211 BLOOD LACTATE DEHYDROGENASE INCREASED 80 0.0050
212 HYPOKALAEMIA 228 0.0049
213 MULTI-ORGAN FAILURE 85 0.0049
214 FULL BLOOD COUNT ABNORMAL 52 0.0049
215 PULMONARY HAEMORRHAGE 38 0.0049
216 COMPLICATIONS OF TRANSPLANTED KIDNEY 11 0.0048
217 OLIGURIA 30 0.0048
218 ADENOVIRUS INFECTION 14 0.0048
219 EPSTEIN-BARR VIRUS INFECTION 30 0.0048
220 POTENTIATING DRUG INTERACTION 16 0.0048
221 OBSTRUCTIVE AIRWAYS DISORDER 53 0.0048
222 TENDON DISORDER 31 0.0047
223 HAEMOLYTIC URAEMIC SYNDROME 11 0.0047
224 BRAIN ABSCESS 12 0.0047
225 SUPRAVENTRICULAR EXTRASYSTOLES 16 0.0047
226 THROMBOTIC MICROANGIOPATHY 46 0.0047
227 VITILIGO 11 0.0047
228 ACUTE LYMPHOCYTIC LEUKAEMIA 13 0.0046
229 LONG QT SYNDROME 11 0.0046
230 DRUG LEVEL ABOVE THERAPEUTIC 21 0.0046
231 LUNG TRANSPLANT 16 0.0045
232 OESOPHAGEAL CANDIDIASIS 18 0.0045
233 CYSTIC FIBROSIS 25 0.0045
234 MUCOSAL DRYNESS 9 0.0045
235 TORSADE DE POINTES 35 0.0045
236 NEPHROPATHY TOXIC 50 0.0044
237 LUNG INFILTRATION 39 0.0044
238 ENTEROCOCCAL INFECTION 21 0.0043
239 HYPERVENTILATION 25 0.0043
240 STAPHYLOCOCCUS TEST POSITIVE 9 0.0043
241 SELF INJURIOUS BEHAVIOUR 13 0.0043
242 SEPTIC SHOCK 185 0.0042
243 ORGANISING PNEUMONIA 21 0.0042
244 DRUG LEVEL DECREASED 43 0.0042
245 SPUTUM DISCOLOURED 40 0.0042
246 CANDIDA INFECTION 71 0.0042
247 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 43 0.0042
248 ENDOPHTHALMITIS 25 0.0042
249 EXPOSED BONE IN JAW 9 0.0041
250 SECRETION DISCHARGE 52 0.0041
251 BACTERIAL TEST POSITIVE 9 0.0040
252 CORNEAL OEDEMA 9 0.0040
253 HEPATIC FUNCTION ABNORMAL 149 0.0040
254 ECCHYMOSIS 27 0.0039
255 OTITIS MEDIA 13 0.0039
256 ACUTE PULMONARY OEDEMA 22 0.0039
257 HYPERURICAEMIA 16 0.0039
258 PULMONARY FUNCTION TEST DECREASED 17 0.0039
259 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 29 0.0039
260 HYPOALBUMINAEMIA 30 0.0039
261 PARAPLEGIA 11 0.0038
262 HYPOGAMMAGLOBULINAEMIA 25 0.0038
263 ELECTROCARDIOGRAM QT PROLONGED 136 0.0038
264 ENCEPHALITIS 26 0.0038
265 STAPHYLOCOCCAL BACTERAEMIA 16 0.0037
266 RHABDOMYOLYSIS 153 0.0037
267 LUNG ADENOCARCINOMA 11 0.0037
268 RALES 21 0.0036
269 NEUTROPHIL COUNT DECREASED 145 0.0036
270 SUBCUTANEOUS ABSCESS 17 0.0035
271 KIDNEY TRANSPLANT REJECTION 17 0.0035
272 TUMOUR LYSIS SYNDROME 31 0.0035
273 CYTOMEGALOVIRUS COLITIS 8 0.0035
274 ORTHOPNOEA 11 0.0035
275 LEFT VENTRICULAR DYSFUNCTION 23 0.0034
276 MULTIPLE MYELOMA 16 0.0034
277 STUPOR 11 0.0034
278 LUNG INFECTION 53 0.0034
279 SINUS CONGESTION 46 0.0034
280 ESCHERICHIA BACTERAEMIA 8 0.0034
281 PNEUMONIA BACTERIAL 31 0.0034
282 AREFLEXIA 9 0.0034
283 HAEMOPTYSIS 93 0.0033
284 HEPATITIS CHOLESTATIC 20 0.0033
285 CYTOLYTIC HEPATITIS 11 0.0033
286 ILEUS 41 0.0033
287 HEPATOTOXICITY 73 0.0033
288 PURULENT DISCHARGE 14 0.0033
289 LIVER FUNCTION TEST ABNORMAL 95 0.0033
290 PETECHIAE 34 0.0033
291 MUCOSAL INFLAMMATION 85 0.0032
292 LEUKOENCEPHALOPATHY 12 0.0032
293 BRONCHOPNEUMONIA 11 0.0032
294 SKIN INFECTION 35 0.0031
295 TOXIC EPIDERMAL NECROLYSIS 47 0.0031
296 NECROSIS 17 0.0031
297 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 29 0.0030
298 AZOTAEMIA 12 0.0030
299 MIXED LIVER INJURY 9 0.0030
300 CLOSTRIDIAL INFECTION 10 0.0030
301 IMMUNOSUPPRESSION 26 0.0029
302 HYDROCEPHALUS 16 0.0029
303 PANCYTOPENIA 162 0.0029
304 MALABSORPTION 15 0.0029
305 BLOOD BILIRUBIN INCREASED 77 0.0028
306 PLEURAL EFFUSION 173 0.0028
307 LOCALISED OEDEMA 13 0.0028
308 ENTEROCOLITIS 16 0.0028
309 DRUG ERUPTION 49 0.0028
310 LIVER DISORDER 122 0.0027
311 SKIN PAPILLOMA 11 0.0027
312 BLOOD ALKALINE PHOSPHATASE INCREASED 68 0.0027
313 ORAL CANDIDIASIS 36 0.0027
314 HYPERTRANSAMINASAEMIA 19 0.0027
315 PARONYCHIA 12 0.0027
316 RENAL IMPAIRMENT 227 0.0027
317 RESPIRATORY FAILURE 197 0.0027
318 PLEURISY 16 0.0027
319 LYMPHADENOPATHY 95 0.0027
320 ERYTHEMA MULTIFORME 25 0.0027
321 SELF-MEDICATION 11 0.0027
322 HYPERKALAEMIA 93 0.0026
323 SQUAMOUS CELL CARCINOMA OF SKIN 16 0.0026
324 MULTIPLE ORGAN DYSFUNCTION SYNDROME 75 0.0026
325 HEPATOMEGALY 26 0.0026
326 JAUNDICE 71 0.0026
327 RHINOVIRUS INFECTION 10 0.0026
328 DEPRESSIVE SYMPTOM 9 0.0026
329 CARDIAC FAILURE ACUTE 17 0.0025
330 SEPSIS 284 0.0025
331 BLOOD PROLACTIN INCREASED 12 0.0025
332 GLUCOSE TOLERANCE IMPAIRED 15 0.0025
333 BLOOD CREATINE PHOSPHOKINASE INCREASED 73 0.0025
334 CARDIOMEGALY 31 0.0025
335 POLYNEUROPATHY 30 0.0025
336 PERIORBITAL OEDEMA 13 0.0025
337 ELECTROLYTE IMBALANCE 29 0.0025
338 UROSEPSIS 23 0.0025
339 ACUTE RESPIRATORY DISTRESS SYNDROME 44 0.0025
340 PULMONARY MASS 37 0.0025
341 ALANINE AMINOTRANSFERASE INCREASED 152 0.0025
342 HAEMOLYTIC ANAEMIA 22 0.0025
343 CHOLESTASIS 47 0.0024
344 OEDEMA 132 0.0024
345 HYPERCALCAEMIA 30 0.0024
346 GENERALISED OEDEMA 30 0.0024
347 FOLLICULITIS 25 0.0024
348 TRANSAMINASES INCREASED 53 0.0024
349 NEPHROGENIC ANAEMIA 11 0.0024
350 SKIN LESION 65 0.0024
351 MUSCLE FATIGUE 10 0.0024
352 BACTERAEMIA 28 0.0024
353 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
354 PHLEBITIS 12 0.0023
355 ASPARTATE AMINOTRANSFERASE INCREASED 124 0.0023
356 THROMBOCYTOPENIA 260 0.0023
357 LYMPHOCYTE COUNT DECREASED 41 0.0023
358 CONJUNCTIVITIS 43 0.0023
359 DRUG-INDUCED LIVER INJURY 72 0.0023
360 GASTROINTESTINAL TOXICITY 11 0.0023
361 OESOPHAGITIS 25 0.0023
362 RESPIRATORY DISTRESS 63 0.0023
363 PULMONARY CONGESTION 30 0.0023
364 NEUROLOGICAL SYMPTOM 13 0.0023
365 PNEUMOTHORAX 36 0.0023
366 PURPURA 20 0.0023
367 INFUSION SITE SWELLING 14 0.0022
368 NEUTROPENIA 302 0.0022
369 PHOTOPSIA 14 0.0022
370 PLATELET COUNT DECREASED 236 0.0022
371 SHOCK HAEMORRHAGIC 18 0.0022
372 DERMATITIS EXFOLIATIVE 11 0.0022
373 BACTERIAL INFECTION 41 0.0022
374 HYPERCHOLESTEROLAEMIA 21 0.0022
375 AMYLASE INCREASED 8 0.0022
376 HYPONATRAEMIA 122 0.0022
377 GASTROINTESTINAL PERFORATION 9 0.0022
378 SPLENOMEGALY 25 0.0021
379 HYPERPYREXIA 9 0.0021
380 STAPHYLOCOCCAL INFECTION 70 0.0021
381 SKIN NECROSIS 11 0.0021
382 VIRAL UPPER RESPIRATORY TRACT INFECTION 10 0.0021
383 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
384 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
385 SWELLING OF EYELID 13 0.0021
386 ATELECTASIS 20 0.0021
387 ATRIOVENTRICULAR BLOCK 16 0.0021
388 ORTHOSTATIC HYPOTENSION 36 0.0021
389 URINE OUTPUT DECREASED 18 0.0021
390 MYELOSUPPRESSION 74 0.0021
391 RENAL FAILURE ACUTE 86 0.0020
392 GALACTORRHOEA 13 0.0020
393 LEUKOPENIA 101 0.0020
394 GASTROINTESTINAL INFECTION 18 0.0020
395 HAEMATOMA 52 0.0020
396 MYELODYSPLASTIC SYNDROME 29 0.0020
397 C-REACTIVE PROTEIN INCREASED 72 0.0020
398 SEASONAL ALLERGY 28 0.0020
399 ANURIA 17 0.0020
400 RESPIRATORY DISORDER 59 0.0020
401 BLOOD UREA INCREASED 33 0.0020
402 SINUS BRADYCARDIA 19 0.0020
403 SUBARACHNOID HAEMORRHAGE 20 0.0020
404 ENDOCARDITIS 10 0.0019
405 HICCUPS 16 0.0019
406 DEVICE RELATED INFECTION 30 0.0019
407 DIFFUSE LARGE B-CELL LYMPHOMA 15 0.0019
408 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
409 CARDIAC FAILURE 155 0.0019
410 SKIN ATROPHY 11 0.0019
411 CHRONIC LYMPHOCYTIC LEUKAEMIA 9 0.0019
412 SERUM FERRITIN INCREASED 10 0.0019
413 VENTRICULAR FIBRILLATION 21 0.0019
414 LIVER INJURY 46 0.0019
415 RHINITIS 15 0.0019
416 REBOUND EFFECT 21 0.0019
417 HEPATITIS ACUTE 12 0.0018
418 HERPES SIMPLEX 12 0.0018
419 ACIDOSIS 14 0.0018
420 NEUROPATHY PERIPHERAL 174 0.0018
421 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 47 0.0018
422 MUSCLE ATROPHY 23 0.0018
423 SQUAMOUS CELL CARCINOMA 17 0.0018
424 THERAPY PARTIAL RESPONDER 28 0.0018
425 ORAL HERPES 35 0.0018
426 HEPATIC FAILURE 54 0.0018
427 HAEMODIALYSIS 15 0.0018
428 COVID-19 PNEUMONIA 21 0.0018
429 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 30 0.0018
430 DRUG TOXICITY 24 0.0018
431 TREATMENT NONCOMPLIANCE 96 0.0018
432 WHITE BLOOD CELL COUNT DECREASED 190 0.0018
433 CACHEXIA 9 0.0017
434 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
435 INTERSTITIAL LUNG DISEASE 84 0.0017
436 LUNG DISORDER 85 0.0017
437 FAILURE TO THRIVE 9 0.0017
438 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
439 PYREXIA 592 0.0017
440 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 121 0.0017
441 LYMPHOPENIA 24 0.0017
442 PHOTOSENSITIVITY REACTION 28 0.0017
443 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
444 ASTHMA 191 0.0017
445 TOXIC SKIN ERUPTION 17 0.0017
446 PERICARDIAL EFFUSION 39 0.0017
447 EOSINOPHIL COUNT INCREASED 14 0.0017
448 BONE MARROW FAILURE 34 0.0017
449 ANAL ABSCESS 9 0.0017
450 ACUTE RESPIRATORY FAILURE 32 0.0017
451 RASH MACULO-PAPULAR 37 0.0017
452 OEDEMA PERIPHERAL 202 0.0017
453 HAEMATURIA 56 0.0016
454 HYPOPHOSPHATAEMIA 12 0.0016
455 BREATH SOUNDS ABNORMAL 8 0.0016
456 ANAEMIA 303 0.0016
457 SOPOR 21 0.0016
458 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
459 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
460 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 13 0.0016
461 HEPATITIS 40 0.0016
462 HERPES VIRUS INFECTION 9 0.0016
463 BLOOD CREATININE INCREASED 102 0.0016
464 EXPOSURE DURING PREGNANCY 97 0.0016
465 BLOOD URIC ACID INCREASED 9 0.0016
466 CARDIOMYOPATHY 23 0.0016
467 PULMONARY TOXICITY 11 0.0016
468 ANOREXIA 20 0.0016
469 METABOLIC DISORDER 9 0.0015
470 UVEITIS 21 0.0015
471 BRADYCARDIA 82 0.0015
472 HYPERPROLACTINAEMIA 10 0.0015
473 VENTRICULAR EXTRASYSTOLES 16 0.0015
474 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
475 TENDERNESS 16 0.0015
476 GASTROINTESTINAL INFLAMMATION 12 0.0015
477 DERMATITIS BULLOUS 11 0.0015
478 BLOOD LACTIC ACID INCREASED 8 0.0015
479 IMMUNE SYSTEM DISORDER 20 0.0015
480 HEPATIC ENZYME INCREASED 103 0.0015
481 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
482 TREATMENT FAILURE 125 0.0015
483 ENCEPHALOPATHY 37 0.0015
484 BRAIN OEDEMA 19 0.0015
485 PNEUMONIA 485 0.0015
486 ACUTE MYOCARDIAL INFARCTION 44 0.0015
487 MYOCARDITIS 17 0.0015
488 NO THERAPEUTIC RESPONSE 18 0.0015
489 MOUTH ULCERATION 31 0.0015
490 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
491 CHOLANGITIS 9 0.0015
492 LIVER FUNCTION TEST INCREASED 31 0.0014
493 LARGE INTESTINE PERFORATION 10 0.0014
494 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 79 0.0014
495 CHOLECYSTITIS 17 0.0014
496 OXYGEN SATURATION DECREASED 80 0.0014
497 TENDONITIS 22 0.0014
498 DISEASE RECURRENCE 67 0.0014
499 IRON DEFICIENCY ANAEMIA 13 0.0014
500 AGRANULOCYTOSIS 26 0.0014
501 DIARRHOEA HAEMORRHAGIC 13 0.0014
502 EXERCISE TOLERANCE DECREASED 8 0.0014
503 BLOOD COUNT ABNORMAL 21 0.0014
504 HAEMORRHOIDS 27 0.0014
505 ABSCESS 22 0.0014
506 ATRIAL FLUTTER 11 0.0014
507 END STAGE RENAL DISEASE 25 0.0014
508 RENAL FAILURE 182 0.0014
509 FACE OEDEMA 23 0.0014
510 UPPER RESPIRATORY TRACT INFECTION 63 0.0014
511 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
512 PULMONARY FIBROSIS 26 0.0014
513 PULMONARY OEDEMA 60 0.0013
514 HYDRONEPHROSIS 10 0.0013
515 THERAPY NON-RESPONDER 60 0.0013
516 TUBULOINTERSTITIAL NEPHRITIS 25 0.0013
517 CHROMATURIA 30 0.0013
518 STATUS EPILEPTICUS 15 0.0013
519 ABNORMAL LOSS OF WEIGHT 9 0.0013
520 CONDITION AGGRAVATED 400 0.0013
521 DERMATITIS ACNEIFORM 8 0.0013
522 ACUTE KIDNEY INJURY 201 0.0013
523 GRAND MAL CONVULSION 12 0.0013
524 HYPOMAGNESAEMIA 18 0.0013
525 PANCREATITIS ACUTE 29 0.0013
526 DERMATITIS 27 0.0013
527 DISEASE PROGRESSION 152 0.0013
528 EYELID PTOSIS 13 0.0013
529 CARDIAC MURMUR 11 0.0013
530 LEUKOCYTOSIS 23 0.0013
531 HEPATOCELLULAR INJURY 18 0.0013
532 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
533 VIRAL INFECTION 42 0.0013
534 BLOOD ALBUMIN DECREASED 10 0.0013
535 CONVULSION 72 0.0013
536 ASCITES 37 0.0013
537 CYSTITIS 40 0.0013
538 CARDIOGENIC SHOCK 18 0.0013
539 ARRHYTHMIA 59 0.0012
540 INFECTION 180 0.0012
541 INFUSION SITE PAIN 16 0.0012
542 PRODUCTIVE COUGH 59 0.0012
543 HERPES ZOSTER 71 0.0012
544 RESPIRATORY TRACT INFECTION 32 0.0012
545 SHOCK 28 0.0012
546 ESCHERICHIA INFECTION 10 0.0012
547 PROTEINURIA 23 0.0012
548 SPINAL COMPRESSION FRACTURE 10 0.0012
549 IMMUNODEFICIENCY 18 0.0012
550 HEMIPLEGIA 10 0.0012
551 VASCULITIS 14 0.0012
552 INFUSION SITE ERYTHEMA 10 0.0012
553 SKIN PLAQUE 10 0.0012
554 IMPAIRED QUALITY OF LIFE 17 0.0012
555 DELIRIUM 41 0.0012
556 CEREBRAL HAEMORRHAGE 42 0.0012
557 PHOTOPHOBIA 22 0.0012
558 SWELLING FACE 76 0.0012
559 PYELONEPHRITIS 10 0.0012
560 HYPERTENSION 244 0.0012
561 CELLULITIS 58 0.0011
562 RASH ERYTHEMATOUS 55 0.0011
563 MITRAL VALVE INCOMPETENCE 13 0.0011
564 COORDINATION ABNORMAL 16 0.0011
565 RESPIRATORY DEPRESSION 14 0.0011
566 HAEMORRHAGE INTRACRANIAL 17 0.0011
567 PHARYNGITIS 14 0.0011
568 HEPATIC STEATOSIS 21 0.0011
569 SINUS TACHYCARDIA 16 0.0011
570 OSTEONECROSIS 37 0.0011
571 INFLAMMATORY BOWEL DISEASE 11 0.0011
572 SKIN ULCER 29 0.0011
573 CAESAREAN SECTION 13 0.0011
574 EJECTION FRACTION DECREASED 17 0.0011
575 APHASIA 33 0.0011
576 EMBOLISM 9 0.0011
577 SINUSITIS 111 0.0011
578 STEVENS-JOHNSON SYNDROME 24 0.0011
579 HYPOXIA 38 0.0011
580 STOMATITIS 65 0.0011
581 NEPHROPATHY 10 0.0011
582 INTESTINAL PERFORATION 12 0.0011
583 CARDIAC ARREST 88 0.0011
584 MUSCULAR WEAKNESS 121 0.0011
585 ALTERED STATE OF CONSCIOUSNESS 23 0.0011
586 CIRCULATORY COLLAPSE 18 0.0011
587 COUGH 295 0.0011
588 RENAL DISORDER 49 0.0011
589 OSTEOMYELITIS 19 0.0010
590 SKIN HYPERPIGMENTATION 9 0.0010
591 WHEEZING 62 0.0010
592 MENTAL STATUS CHANGES 29 0.0010
593 GASTROINTESTINAL HAEMORRHAGE 87 0.0010
594 GASTROINTESTINAL DISORDER 93 0.0010
595 RENAL PAIN 11 0.0010
596 DRUG INTOLERANCE 100 0.0010
597 PNEUMONITIS 28 0.0010
598 GASTROENTERITIS 15 0.0010
599 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
600 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
601 CEREBRAL INFARCTION 25 0.0010
602 RENAL TUBULAR NECROSIS 10 0.0010
603 HYPERGLYCAEMIA 37 0.0010
604 LOWER RESPIRATORY TRACT INFECTION 46 0.0010
605 OBESITY 16 0.0010
606 HYPOCALCAEMIA 19 0.0010
607 BLISTER 56 0.0010
608 CARDIAC FAILURE CONGESTIVE 80 0.0010
609 OPTIC NEURITIS 9 0.0010
610 DECUBITUS ULCER 8 0.0010
611 PRODUCT USE IN UNAPPROVED INDICATION 243 0.0010
612 ASPHYXIA 8 0.0010
613 TINNITUS 45 0.0010
614 EAR DISCOMFORT 10 0.0010
615 EOSINOPHILIA 17 0.0010
616 VENTRICULAR TACHYCARDIA 16 0.0010
617 ACUTE CORONARY SYNDROME 8 0.0010
618 HEPATIC ENCEPHALOPATHY 9 0.0010
619 NERVOUS SYSTEM DISORDER 30 0.0010
620 RHINORRHOEA 62 0.0010
621 ARTERIOSCLEROSIS 9 0.0010
622 LEUKAEMIA 9 0.0010
623 HAEMATOTOXICITY 9 0.0009
624 EYELID OEDEMA 11 0.0009
625 INCONTINENCE 10 0.0009
626 BRONCHITIS 70 0.0009
627 DIABETES MELLITUS 72 0.0009
628 HYPOTHYROIDISM 30 0.0009
629 CHILLS 110 0.0009
630 BODY TEMPERATURE INCREASED 19 0.0009
631 DYSPNOEA EXERTIONAL 35 0.0009
632 HALLUCINATION 70 0.0009
633 DIALYSIS 13 0.0009
634 RASH MACULAR 32 0.0009
635 DRUG EXPOSURE DURING PREGNANCY 31 0.0009
636 LYMPHOMA 14 0.0009
637 COAGULOPATHY 15 0.0009
638 OSTEOPOROSIS 37 0.0009
639 SKIN DISORDER 30 0.0009
640 HYPERTHYROIDISM 13 0.0009
641 BLOOD POTASSIUM DECREASED 27 0.0009
642 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 43 0.0009
643 EYE INFECTION 10 0.0009
644 TACHYPNOEA 12 0.0009
645 PAIN IN JAW 25 0.0009
646 PELVIC PAIN 16 0.0009
647 PNEUMONIA ASPIRATION 22 0.0009
648 DYSPNOEA 494 0.0009
649 DRUG INEFFECTIVE 1146 0.0009
650 NEURALGIA 21 0.0009
651 BLOOD POTASSIUM INCREASED 14 0.0009
652 SKIN EXFOLIATION 72 0.0009
653 CHEST DISCOMFORT 87 0.0008
654 ABORTION SPONTANEOUS 34 0.0008
655 ABDOMINAL PAIN 197 0.0008
656 AGITATION 62 0.0008
657 DYSURIA 31 0.0008
658 SUBDURAL HAEMATOMA 12 0.0008
659 PARALYSIS 12 0.0008
660 TASTE DISORDER 17 0.0008
661 DYSPHONIA 49 0.0008
662 HAEMOGLOBIN DECREASED 86 0.0008
663 ADVERSE REACTION 11 0.0008
664 HYPOKINESIA 12 0.0008
665 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
666 FLUID OVERLOAD 12 0.0008
667 BURSITIS 10 0.0008
668 NOCTURIA 10 0.0008
669 MELAENA 18 0.0008
670 CYTOPENIA 10 0.0008
671 MYALGIA 138 0.0008
672 CHEST PAIN 150 0.0008
673 ABASIA 20 0.0008
674 HOSPITALISATION 124 0.0008
675 CYST 10 0.0008
676 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 42 0.0008
677 EPISTAXIS 60 0.0008
678 INFLUENZA LIKE ILLNESS 66 0.0008
679 AGEUSIA 20 0.0008
680 FISTULA 9 0.0008
681 BLOOD CALCIUM DECREASED 9 0.0008
682 COMA 38 0.0008
683 BRAIN INJURY 8 0.0008
684 HYPOAESTHESIA ORAL 12 0.0008
685 INTENTIONAL SELF-INJURY 16 0.0008
686 NEOPLASM 9 0.0008
687 RIB FRACTURE 16 0.0008
688 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
689 HYPOTENSION 155 0.0008
690 BRONCHOSPASM 11 0.0008
691 DIPLOPIA 20 0.0008
692 RED BLOOD CELL COUNT DECREASED 22 0.0008
693 OSTEONECROSIS OF JAW 19 0.0008
694 ATRIAL FIBRILLATION 74 0.0008
695 SYNCOPE 76 0.0008
696 SCAR 13 0.0008
697 HAEMATOCRIT DECREASED 15 0.0008
698 METABOLIC ACIDOSIS 24 0.0007
699 DYSARTHRIA 28 0.0007
700 FOOT FRACTURE 14 0.0007
701 GASTRIC ULCER 14 0.0007
702 ASPIRATION 8 0.0007
703 ABDOMINAL DISTENSION 76 0.0007
704 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
705 OFF LABEL USE 637 0.0007
706 CONSTIPATION 157 0.0007
707 CARDIO-RESPIRATORY ARREST 30 0.0007
708 BLOOD TEST ABNORMAL 10 0.0007
709 RASH 310 0.0007
710 HALLUCINATION, VISUAL 15 0.0007
711 TACHYCARDIA 63 0.0007
712 URINARY INCONTINENCE 21 0.0007
713 DISORIENTATION 28 0.0007
714 HEPATIC CYTOLYSIS 9 0.0007
715 PREMATURE BABY 21 0.0007
716 ERYTHEMA 143 0.0007
717 GASTRIC HAEMORRHAGE 8 0.0007
718 DECREASED APPETITE 161 0.0007
719 TREMOR 115 0.0007
720 GENERAL PHYSICAL HEALTH DETERIORATION 80 0.0007
721 URINARY RETENTION 23 0.0007
722 DEAFNESS 18 0.0007
723 EPILEPSY 21 0.0007
724 URINARY TRACT INFECTION 117 0.0007
725 GASTRITIS 18 0.0007
726 NIGHT SWEATS 22 0.0007
727 INFLAMMATION 35 0.0007
728 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
729 THERAPEUTIC RESPONSE DECREASED 41 0.0007
730 GLAUCOMA 13 0.0007
731 THIRST 12 0.0007
732 HYPOAESTHESIA 100 0.0007
733 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
734 HYPOPHAGIA 17 0.0007
735 TOXICITY TO VARIOUS AGENTS 112 0.0007
736 INFUSION RELATED REACTION 44 0.0007
737 DYSGEUSIA 49 0.0007
738 OSTEOPENIA 10 0.0007
739 ACUTE HEPATIC FAILURE 9 0.0007
740 PERICARDITIS 11 0.0007
741 PRODUCT USE ISSUE 123 0.0007
742 MUSCULOSKELETAL CHEST PAIN 10 0.0006
743 CHRONIC KIDNEY DISEASE 49 0.0006
744 MIDDLE INSOMNIA 12 0.0006
745 PARAESTHESIA 101 0.0006
746 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
747 RENAL INJURY 19 0.0006
748 HYPOGLYCAEMIA 31 0.0006
749 BLOOD SODIUM DECREASED 12 0.0006
750 BLOOD URINE PRESENT 12 0.0006
751 PALPITATIONS 74 0.0006
752 LOCAL SWELLING 11 0.0006
753 ASTHENIA 237 0.0006
754 LACRIMATION INCREASED 19 0.0006
755 PERITONITIS 13 0.0006
756 VOMITING 295 0.0006
757 DIARRHOEA 405 0.0006
758 POST PROCEDURAL COMPLICATION 12 0.0006
759 RASH PAPULAR 14 0.0006
760 ANAPHYLACTIC SHOCK 16 0.0006
761 UNRESPONSIVE TO STIMULI 16 0.0006
762 CONFUSIONAL STATE 100 0.0006
763 IMPAIRED HEALING 20 0.0006
764 WEIGHT INCREASED 136 0.0006
765 COLITIS 23 0.0006
766 HEART RATE INCREASED 60 0.0006
767 PSYCHOMOTOR HYPERACTIVITY 10 0.0006
768 MALAISE 261 0.0006
769 MEDICATION ERROR 33 0.0006
770 NAUSEA 469 0.0006
771 VERTIGO 36 0.0006
772 PALLOR 16 0.0006
773 WEIGHT DECREASED 163 0.0006
774 CHOLELITHIASIS 19 0.0006
775 CYANOSIS 9 0.0006
776 VISUAL ACUITY REDUCED 19 0.0006
777 ULCER 9 0.0006
778 VISUAL IMPAIRMENT 70 0.0006
779 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
780 IRRITABLE BOWEL SYNDROME 12 0.0006
781 INTESTINAL OBSTRUCTION 21 0.0006
782 PAIN OF SKIN 15 0.0006
783 BLOOD PRESSURE DECREASED 37 0.0006
784 JOINT SWELLING 67 0.0006
785 HAEMORRHAGE 58 0.0006
786 PRODUCT PRESCRIBING ISSUE 12 0.0006
787 DYSPEPSIA 54 0.0005
788 DEHYDRATION 73 0.0005
789 MANIA 9 0.0005
790 DIABETIC KETOACIDOSIS 13 0.0005
791 RASH GENERALISED 14 0.0005
792 EYE SWELLING 20 0.0005
793 RECTAL HAEMORRHAGE 23 0.0005
794 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
795 ANHEDONIA 14 0.0005
796 HEMIPARESIS 9 0.0005
797 FRACTURE 10 0.0005
798 PULMONARY HYPERTENSION 11 0.0005
799 POLLAKIURIA 22 0.0005
800 ANGINA PECTORIS 15 0.0005
801 DRY EYE 26 0.0005
802 DRUG PRESCRIBING ERROR 10 0.0005
803 ANKLE FRACTURE 8 0.0005
804 BONE PAIN 30 0.0005
805 GASTROOESOPHAGEAL REFLUX DISEASE 41 0.0005
806 PSYCHOTIC DISORDER 15 0.0005
807 HAEMATOCHEZIA 28 0.0005
808 LOSS OF CONSCIOUSNESS 65 0.0005
809 ABDOMINAL PAIN UPPER 104 0.0005
810 ADVERSE DRUG REACTION 45 0.0005
811 DEMENTIA 14 0.0005
812 CYTOKINE RELEASE SYNDROME 10 0.0005
813 FULL BLOOD COUNT DECREASED 10 0.0005
814 SPEECH DISORDER 26 0.0005
815 RESTLESSNESS 18 0.0005
816 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
817 PLASMA CELL MYELOMA 19 0.0005
818 BURNING SENSATION 34 0.0005
819 TOOTH LOSS 10 0.0005
820 PRURITUS 184 0.0005
821 BONE DENSITY DECREASED 15 0.0005
822 ADVERSE EVENT 44 0.0005
823 EYE PRURITUS 16 0.0005
824 PANCREATITIS 25 0.0005
825 CARDIOVASCULAR DISORDER 12 0.0005
826 INCREASED APPETITE 9 0.0005
827 THROAT IRRITATION 21 0.0005
828 DYSKINESIA 19 0.0005
829 PERIPHERAL SWELLING 72 0.0005
830 OCULAR HYPERAEMIA 22 0.0005
831 PULMONARY EMBOLISM 44 0.0005
832 KIDNEY INFECTION 9 0.0005
833 HYPERSENSITIVITY 85 0.0005
834 NASOPHARYNGITIS 84 0.0005
835 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
836 SINUS DISORDER 9 0.0005
837 FATIGUE 352 0.0005
838 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
839 HEAD DISCOMFORT 8 0.0005
840 GLOSSODYNIA 10 0.0004
841 EYE PAIN 25 0.0004
842 GASTROENTERITIS VIRAL 8 0.0004
843 DYSPHAGIA 42 0.0004
844 ALOPECIA 86 0.0004
845 PAIN IN EXTREMITY 129 0.0004
846 NIGHTMARE 15 0.0004
847 HEADACHE 268 0.0004
848 DISTURBANCE IN ATTENTION 23 0.0004
849 SEIZURE 49 0.0004
850 ARTHRALGIA 176 0.0004
851 COVID-19 74 0.0004
852 OROPHARYNGEAL PAIN 39 0.0004
853 INSOMNIA 112 0.0004
854 LIMB DISCOMFORT 13 0.0004
855 BLOOD PRESSURE INCREASED 64 0.0004
856 DEPRESSED MOOD 22 0.0004
857 MATERNAL EXPOSURE DURING PREGNANCY 37 0.0004
858 FLUID RETENTION 21 0.0004
859 PANIC ATTACK 15 0.0004
860 ANXIETY 117 0.0004
861 MENSTRUATION IRREGULAR 11 0.0004
862 CHOKING 8 0.0004
863 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
864 MUSCLE SPASMS 75 0.0004
865 ANGIOEDEMA 18 0.0004
866 MOBILITY DECREASED 29 0.0004
867 NEOPLASM PROGRESSION 14 0.0004
868 SOMNOLENCE 81 0.0004
869 MUSCULOSKELETAL PAIN 21 0.0004
870 RESPIRATORY ARREST 11 0.0004
871 ABNORMAL DREAMS 11 0.0004
872 DIVERTICULITIS 11 0.0004
873 ABDOMINAL PAIN LOWER 10 0.0004
874 EYE DISORDER 13 0.0004
875 PRODUCT AVAILABILITY ISSUE 9 0.0004
876 HYPOACUSIS 17 0.0004
877 HAEMATEMESIS 10 0.0004
878 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
879 VISION BLURRED 54 0.0004
880 SKIN DISCOLOURATION 18 0.0004
881 RASH PRURITIC 21 0.0004
882 HEAD INJURY 12 0.0004
883 OSTEOARTHRITIS 16 0.0004
884 NASAL CONGESTION 22 0.0004
885 MALIGNANT NEOPLASM PROGRESSION 38 0.0004
886 FAECES DISCOLOURED 8 0.0004
887 MENTAL DISORDER 16 0.0004
888 INTENTIONAL PRODUCT MISUSE 32 0.0004
889 LETHARGY 21 0.0004
890 ECZEMA 19 0.0004
891 DIZZINESS 181 0.0004
892 ANAPHYLACTIC REACTION 20 0.0004
893 FEELING COLD 10 0.0004
894 URTICARIA 60 0.0004
895 WOUND 10 0.0004
896 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
897 HEART RATE IRREGULAR 8 0.0004
898 CONTUSION 34 0.0004
899 DEPRESSION 80 0.0004
900 INTENTIONAL DOSE OMISSION 10 0.0004
901 NEPHROLITHIASIS 16 0.0003
902 PHARMACEUTICAL PRODUCT COMPLAINT 9 0.0003
903 FLUSHING 35 0.0003
904 SEDATION 9 0.0003
905 INFLUENZA 38 0.0003
906 NECK PAIN 19 0.0003
907 GAIT DISTURBANCE 65 0.0003
908 DEEP VEIN THROMBOSIS 22 0.0003
909 BACK PAIN 77 0.0003
910 PAIN 203 0.0003
911 CRYING 12 0.0003
912 EYE IRRITATION 19 0.0003
913 FIBROMYALGIA 8 0.0003
914 FEELING HOT 20 0.0003
915 DEATH 273 0.0003
916 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
917 MOVEMENT DISORDER 10 0.0003
918 SWELLING 29 0.0003
919 FALL 103 0.0003
920 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
921 FEELING ABNORMAL 74 0.0003
922 SUICIDAL IDEATION 28 0.0003
923 ABNORMAL BEHAVIOUR 12 0.0003
924 ILLNESS 31 0.0003
925 EAR INFECTION 8 0.0003
926 DRUG ABUSE 25 0.0003
927 AGGRESSION 15 0.0003
928 CARDIAC DISORDER 28 0.0003
929 TYPE 2 DIABETES MELLITUS 10 0.0003
930 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
931 DRY MOUTH 24 0.0003
932 BLINDNESS 12 0.0003
933 LUNG NEOPLASM MALIGNANT 12 0.0003
934 ARTHROPATHY 16 0.0003
935 MYOCARDIAL INFARCTION 50 0.0003
936 THROMBOSIS 23 0.0003
937 HEART RATE DECREASED 10 0.0003
938 SUICIDE ATTEMPT 17 0.0003
939 ILL-DEFINED DISORDER 17 0.0003
940 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
941 HYPERHIDROSIS 36 0.0003
942 VAGINAL HAEMORRHAGE 12 0.0003
943 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
944 DYSSTASIA 8 0.0003
945 BLOOD GLUCOSE DECREASED 13 0.0003
946 GAIT INABILITY 9 0.0003
947 CATARACT 16 0.0003
948 BALANCE DISORDER 23 0.0003
949 FLATULENCE 15 0.0003
950 CORONARY ARTERY DISEASE 8 0.0003
951 ABDOMINAL DISCOMFORT 44 0.0003
952 SKIN IRRITATION 12 0.0003
953 COGNITIVE DISORDER 12 0.0003
954 THERAPY CESSATION 13 0.0003
955 IRRITABILITY 15 0.0002
956 INTENTIONAL OVERDOSE 16 0.0002
957 INJURY 17 0.0002
958 MIGRAINE 23 0.0002
959 SLEEP DISORDER 17 0.0002
960 NEOPLASM MALIGNANT 16 0.0002
961 BLOOD GLUCOSE INCREASED 45 0.0002
962 THERAPY INTERRUPTED 17 0.0002
963 ACNE 18 0.0002
964 DRUG DOSE OMISSION 39 0.0002
965 GASTRIC DISORDER 8 0.0002
966 AMNESIA 15 0.0002
967 PRODUCT DOSE OMISSION 15 0.0002
968 DISCOMFORT 14 0.0002
969 RHEUMATOID ARTHRITIS 26 0.0002
970 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
971 SURGERY 12 0.0002
972 DRUG EFFECT DECREASED 11 0.0002
973 PRODUCT DOSE OMISSION ISSUE 60 0.0002
974 ARTHRITIS 16 0.0002
975 SKIN BURNING SENSATION 14 0.0002
976 DRY SKIN 26 0.0002
977 INCORRECT DOSE ADMINISTERED 44 0.0002
978 DERMATITIS ATOPIC 10 0.0002
979 CEREBROVASCULAR ACCIDENT 32 0.0002
980 OVERDOSE 40 0.0002
981 MUSCULOSKELETAL STIFFNESS 16 0.0002
982 EMOTIONAL DISTRESS 22 0.0002
983 MEMORY IMPAIRMENT 24 0.0002
984 UNEVALUABLE EVENT 13 0.0002
985 PSORIASIS 15 0.0001
986 INJECTION SITE ERYTHEMA 14 0.0001
987 INJECTION SITE BRUISING 9 0.0001
988 INJECTION SITE HAEMORRHAGE 9 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
990 HOT FLUSH 8 0.0001
991 INJECTION SITE PAIN 31 0.0001
992 NO ADVERSE EVENT 16 0.0001
993 PRODUCT QUALITY ISSUE 10 0.0001
994 DRUG DEPENDENCE 11 0.0001